Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Association between beta-interferon exposure and hospital events in multiple sclerosis.
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
Effect of smoking on multiple sclerosis: a meta-analysis.
Neuroimmunology: Phase II trial demonstrates efficacy of erythropoietin in optic neuritis.
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
Interferon beta-1b
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
European Commission approves Genzyme’s multiple sclerosis treatment Lemtrada™ (alemtuzumab)
Microglia in health and disease.
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
The employment concerns of Americans with multiple sclerosis: Perspectives from a national sample.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.

Pages